scholarly journals Predicting erosive disease in rheumatoid arthritis. A longitudinal study of changes in bone density using digital X-ray radiogrammetry: a pilot study

Rheumatology ◽  
2004 ◽  
Vol 43 (12) ◽  
pp. 1561-1564 ◽  
Author(s):  
A. Stewart
2005 ◽  
Vol 8 (2) ◽  
pp. 90-98
Author(s):  
Bagus P. P. SURYANA ◽  
Robert K. WILL ◽  
Annie LIM ◽  
Bill BREIDAHL

2014 ◽  
Vol 73 (Suppl 2) ◽  
pp. 396.3-397
Author(s):  
S.Z. Prodanovic ◽  
G. Radunovic ◽  
M. Zlatanovic ◽  
K. Simic-Pasalic ◽  
M. Bukilica-Sefik ◽  
...  

2015 ◽  
Vol 6 (2) ◽  
pp. 18-26
Author(s):  
Adriane Yaeko Togashi ◽  
Adair Santa Catarina ◽  
Lucas Renato Piana Batistussi ◽  
Guilherme Coelho

Reumatismo ◽  
2018 ◽  
Vol 70 (2) ◽  
pp. 67
Author(s):  
A. Alunno ◽  
O. Bistoni ◽  
F. Pratesi ◽  
F. Topini ◽  
I. Puxeddu ◽  
...  

In recent years several antibodies against citrullinated peptides (ACPAs) have been identified in patients with rheumatoid arthritis (RA) and their pathogenic, diagnostic and prognostic significance is under intense investigation. Among ACPAs, those targeting citrullinated alpha enolase (anti-CEP1) have been identified in RA but data about their ability to predict the development of erosive disease are conflicting. Furthermore, no data are currently available concerning their possible association with extra-articular manifestations (EAMs) in RA. The aim of this study was to investigate the prevalence and significance of anti-CEP1 from a prognostic point of view. In this pilot study we confirmed that anti-CEP1 Abs are associated with higher prevalence of bone erosions, but we also provided the first evidence of an association between anti-CEP1 Abs and RA interstitial lung disease (ILD). These results provide the basis to investigate the association between anti-CEP1 Abs and EAMs in larger cohorts of RA patients to possibly confirm its role as biomarker for RA-ILD.


2015 ◽  
pp. 50-58
Author(s):  
Thi Dung Nguyen ◽  
Tam Vo

Background: The patients on hemodialysis have a significantly decreased quality of life. One of many problems which reduce the quality of life and increase the mortality in these patients is osteoporosis and osteoporosis associated fractures. Objectives: To assess the bone density of those on hemodialysis by dual energy X ray absorptiometry and to examine the risk factors of bone density reduction in these patients. Patients and Method: This is a cross-sectional study, including 93 patients on chronic hemodialysis at the department of Hemodialysis at Cho Ray Hospital. Results: Mean bone densities at the region of interest (ROI) neck, trochanter, Ward triangle, intertrochanter and total neck are 0.603 ± 0.105; 0.583 ± 0.121; 0.811 ± 0.166; 0.489 ± 0.146; 0.723 ± 0.138 g/cm2 respectively. The prevalences of osteoporosis at those ROI are 39.8%, 15.1%; 28%; 38.7%; and 26.9% respectively. The prevalences of osteopenia at those ROI are 54.8%; 46.3%; 60.2%; 45.2% and 62.7% respectively. The prevalence of osteopososis in at least one ROI is 52.7% and the prevalence of osteopenia in at least one ROI is 47.3%. There are relations between the bone density at the neck and the gender of the patient and the albuminemia. Bone density at the trochanter is influenced by gender, albuminemia, calcemia and phosphoremia. Bone density at the intertrochanter is affected by the gender. Bone density at the Ward triangle is influenced by age and albuminemia. Total neck bone density is influenced by gender, albuminemia and phosphoremia. Conclusion: Osteoporosis in patients on chronic hemodialysis is an issue that requires our attention. There are many interventionable risk factors of bone density decrease in these patients. Key words: Osteoporosis, DEXA, chronic renal failure, chronic hemodialysis


Sign in / Sign up

Export Citation Format

Share Document